Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks.

scientific article published in November 2017

Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/10717544.2017.1337823
P698PubMed publication ID28617150

P50authorMohammed A AhmedQ56953135
Mohammed ElmowafyQ58337113
Khaled ShalabyQ83999503
Hany M. IbrahimQ41890363
P2093author name stringAyman Salama
Hossam Hefesha
P2860cites workNanostructured lipid carrier (NLC) based gel of celecoxib.Q50951651
Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism.Q51171804
Nanostructured lipid carriers (NLC) in cosmetic dermal products.Q52925313
PD-PK evaluation of freeze-dried atorvastatin calcium-loaded poly-ε-caprolactone nanoparticles.Q53767751
Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseQ29614930
Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailabilityQ33578636
Lipids, lipophilic drugs, and oral drug delivery-some emerging conceptsQ33976182
Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tractQ34190317
Intestinal lymphatic drug transport: an updateQ34328456
Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs)Q34444568
Alpha-lipoic acid-loaded nanostructured lipid carrier: sustained release and biocompatibility to HaCaT cells in vitroQ35021953
Effect of pluronic P85 on ATPase activity of drug efflux transportersQ37179672
Suppressor of cytokine signaling-3 (SOCS-3) and a deficit of serine/threonine (Ser/Thr) phosphoproteins involved in leptin transduction mediate the effect of fructose on rat liver lipid metabolismQ39928700
Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.Q40141200
Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatmentQ42788473
Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokineticsQ43198970
Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterizationQ43591380
Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycinQ44415253
Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.Q44907355
Enhancement of Bioavailability and Pharmacodynamic Effects of Thymoquinone Via Nanostructured Lipid Carrier (NLC) FormulationQ46337926
Enhanced bioavailability of nano-sized chitosan-atorvastatin conjugate after oral administration to ratsQ46406341
Mild hepatic fibrosis in cholesterol and sodium cholate diet-fed ratsQ46418029
Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) processQ46688330
Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in miceQ46711804
Liquid chromatography/mass spectrometric studies on atorvastatin and its stress degradation productsQ46773853
Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.Q46786043
Size-dependent absorption mechanism of polymeric nanoparticles for oral delivery of protein drugsQ47290659
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)932-941
P577publication date2017-11-01
P1433published inDrug DeliveryQ5308838
P1476titleAtorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks
P478volume24

Reverse relations

cites work (P2860)
Q99728602Atorvastatin Solid Lipid Nanoparticles as a Promising Approach for Dermal Delivery and an Anti-inflammatory Agent
Q90528642Development of novel rosuvastatin nanostructured lipid carriers for oral delivery in an animal model
Q58032213Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs

Search more.